MetaCap

Nektar Therapeutics Statistics

NASDAQ: NKTRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

30.20-2.34 (-7.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Nektar Therapeutics by the numbers

Nektar Therapeutics has a market capitalization of $1.03 billion based on 34.21M shares outstanding. With trailing EPS of $-22.47, Nektar Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 32.3% below its 50-day average and 53.5% below its 200-day average.

Average daily trading volume is 1.12M shares, or about $33.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NKTR valuation vs. peer median

NKTR compared with the median of 8 peer companies
MetricNKTRPeer medianDifference
Market cap$1.03B$1.02B+1%
Avg. volume1.12M620.37K+81%

Peer median across 8 companies: CTY, ANRO, JBIO, KARD, OMER, SPTX, CYRX, AAPG.

Valuation

Price / sales (latest FY)
18.71
EPS (TTM)
$-22.47

Price and trading

Previous close
32.54
Open
31.66
Day range
30.13 – 32.35
52-week range
30.13 – 109.00
52-week change
-44.36%
Beta
—
Volume
1.02M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
1.03B
Forward Pe
-3.04
Eps
-22.47
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
109.00
Week52 Low
30.13
Avg Volume
1.12M
Shares Outstanding
34.21M
Ma50
44.60
Ma200
64.96
Earnings Date
Nov 12, 2026
Pct From52w High
-72.29%
Pct From52w Low
0.23%

Related